Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0NU3J
|
||||
| Former ID |
DNC013762
|
||||
| Drug Name |
NOSTOCARBOLINE
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C12H10ClIN2
|
||||
| Canonical SMILES |
C[N+]1=CC2=C(C=C1)C3=C(N2)C=CC(=C3)Cl.[I-]
|
||||
| InChI |
1S/C12H9ClN2.HI/c1-15-5-4-9-10-6-8(13)2-3-11(10)14-12(9)7-15;/h2-7H,1H3;1H
|
||||
| InChIKey |
YSZAXPOWTBYIJG-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Cholinesterase | Target Info | Inhibitor | [1] | |
| PANTHER Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | ||||
| Muscarinic acetylcholine receptor 2 and 4 signaling pathway | |||||
| Nicotinic acetylcholine receptor signaling pathway | |||||
| WikiPathways | Irinotecan Pathway | ||||
| References | |||||
| REF 1 | J Nat Prod. 2005 Dec;68(12):1793-5.Nostocarboline: isolation and synthesis of a new cholinesterase inhibitor from Nostoc 78-12A. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.